ALC vs WST
Alcon Inc vs West Pharmaceutical Services — AI-powered side-by-side comparison
VS
WST
West Pharmaceutical Services
71
Buy
| Metric | ALC | WST |
|---|
| AI Score |
68
|
71
|
| Price |
$71.78
|
$353.62
|
| P/E Ratio |
43.26×
|
44.99×
|
| ROE |
4.4%
|
15.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
36.8%
|
| Debt / Equity |
0.24×
|
0.10×
|
| Dividend Yield |
0.5%
|
0.2%
|
| RSI (14) |
66.2
|
61.3
|
| Beta |
0.703
|
1.159
|
| Expected Upside |
+14.1%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALC versus WST.
WST leads by 3 points.
WST scores 71/100 (Buy) versus ALC at 68/100 (Buy).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- No news coverage in the last 14 days -- limited independent confirmation either way — News
WST Committee View
100% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical